According to a new study, adults with AD have a higher incidence of systemic, autoimmune, and psychiatric comorbidities than those without.

Patients being treated with dupilumab for atopic dermatitis may experience less severe Covid-19 symptoms, according to a new study.

Research has suggested that intrauterine mechanisms of overweight women in pre-pregnancy may have increased risks of their infant having AD.

Researchers have linked a key protein called TWEAK to inflammation in psoriasis patients.

A new study tested risankizumab in patients with severe asthma and found it worsened their asthma symptoms.

Researchers have surveyed 137 respondents from a psoriatic arthritis registry for characteristics, therapies and medication preference.

Results of a phase 3 trial have linked dupilumab to significantly reduced skin lesions and itch when compared to placebo.

Researchers have found that skin regeneration is associated with the ability of skin stem cells to move toward the injury.